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Dear Editor, 
In 2014 the NIHR announced that they would discontinue funding for the NHS Economic Evaluations 
Database (NHS EED) and the Database of Abstracts and Reviews of Effects (DARE) at the end of 
March 2015.1 Over the past 12 months, the InterTASC Information Specialist Sub-Group (ISSG) – a 
group of information professionals who carry out literature searching to support the UK Health 
Technology Assessment programme – have been reviewing the affect that the loss of these 
databases will have on the quality and efficiency of evidence-based medicine research.  
NHS EED and DARE were commissioned in 1994 by the NHS Research and Development Programme 
and maintained by the University of York Centre for Reviews and Dissemination (CRD). The aim of 
NHS EED was to bring together economic evaluations that were spread across many databases and 
paper resources. The database received coverage in the BMJ2 and research showed that it was 
valued by its users. 3 DARE performed a similar role for systematic reviews and included a quality 
appraisal by experienced systematic reviewers with each abstract. By March 2015 there were a total 
of 52,000 abstract indexed across the two databases.4 
We consider that the loss of these databases has adversely affected the identification of high quality 
evidence. For example, a clinician might take 60 minutes or more to make an appraisal of the quality 
of a review. The existence of the DARE record saves this time (multiplied by every clinician user). We 
also suspect a volume and outcome relationship, i.e. a better appraisal will be done by those who do 
conduct appraisals regularly than clinicians who have limited time and resources to conduct 
appraisals. In addition, without these databases it has been harder and less efficient for us as 
information specialists to identify economic evaluations and reviews, respectively.  
Though large health care databases such as MEDLINE and EMBASE continue to thrive, we feel it is 
important to highlight that smaller databases play an important role in the identification of 
evidence. We should not mourn silently when these resources are discontinued, but make known to 
funders that the loss of such resources is keenly felt amongst the research communities who 
regularly use them. 
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